Apple Watch glucose monitoring edges closer as non-invasive breath-test tech enters FDA trials

Millions die annually from diabetes; early non-invasive detection could prevent deaths and improve outcomes for undiagnosed patients.

For a decade, the promise of a wearable that could silently watch over one of humanity's most prevalent and underdiagnosed diseases has remained just out of reach. Now, a pendant-sized device called Isaac — which reads the chemical whispers in human breath to detect signs of diabetes — has entered FDA clinical trials at Indiana University, offering the most credible path yet toward non-invasive glucose monitoring. With over ten percent of adults living with diabetes and nearly half unaware of it, the distance between a laboratory trial and a wrist-worn device has rarely carried such weight.

Apple Watch glucose monitoring edges closer as non-invasive breath-test tech enters FDA trials

Cobertura Relacionada

Receba o Register no seu e-mail